IMM-H014

N/A

Report date: 2025/06/19 11:38:52
NME

Base Information

Drug NameIMM-H014
Drug Alias NameIMM-H014WS-117
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNuclear respiratory factor 1 stimulantsNuclear factor erythroid 2-related factor 2 stimulants
TargetsNuclear respiratory factor 1Nuclear factor erythroid 2-related factor 2
Therapy Area/IndicationsMetabolic Dysfunction-Associated Steatotic Liver Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesInstitue Of Materia Medica Chinese Academy Of Medical ScienceChangchun Intellicrown Pharmaceutical Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesChangchun Intellicrown Pharmaceutical Co LtdInstitue Of Materia Medica Chinese Academy Of Medical Science
Inactive CompaniesN/A
Active IndicationsMetabolic Dysfunction-Associated Steatotic Liver Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A